You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 281 No. 23, June 16, 1999 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (148)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Neurology
 •Neuro-otology
 •Otolaryngology/ Head & Neck Surgery
 •Hearing Loss/ Deafness
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Carrier Rates in the Midwestern United States for GJB2 Mutations Causing Inherited Deafness

Glenn E. Green, MD; Daryl A. Scott; Joshua M. McDonald; George G. Woodworth, PhD; Val C. Sheffield, MD, PhD; Richard J. H. Smith, MD

JAMA. 1999;281:2211-2216.

Context  Mutations in the GJB2 gene are the most common known cause of inherited congenital severe-to-profound deafness. The carrier frequency of these mutations is not known.

Objectives  To determine the carrier rate of deafness-causing mutations in GJB2 in the midwestern United States and the prevalence of these mutations in persons with congenital sensorineural hearing loss ranging in severity from moderate to profound, and to derive revised data for counseling purposes.

Design  Laboratory analysis, performed in 1998, of samples from probands with hearing loss for mutations in GJB2 using an allele-specific polymerase chain reaction assay, single-strand conformation polymorphism analysis, and direct sequencing.

Setting and Subjects  Fifty-two subjects younger than 19 years sequentially referred to a midwestern tertiary referral center for hearing loss or cochlear implantation, with moderate-to-profound congenital hearing loss of unknown cause, parental nonconsanguinity, and nonsyndromic deafness with hearing loss limited to a single generation; 560 control neonates were screened for the 35delG mutation.

Main Outcome Measure  Prevalence of mutations in the GJB2 gene by congenital deafness status.

Results  Of 52 sequential probands referred for congenital sensorineural hearing loss, 22 (42%) were found to have GJB2 mutations. The 35delG mutation was identified in 29 of the 41 mutant alleles. Of probands' sibs, all homozygotes and compound heterozygotes had deafness. Fourteen of 560 controls were 35delG heterozygotes, for a carrier rate expressed as a mean (SE) of 2.5% (0.66%). The carrier rate for all recessive deafness-causing GJB2 mutations was determined to be 3.01% (probable range, 2.54%-3.56%). Calculated sensitivity and specificity for a screening test based on 35delG mutation alone were 96.9% and 97.4%, respectively, and observed values were 94% and 97%, respectively.

Conclusions  Our data suggest that mutations in GJB2 are the leading cause of moderate-to-profound congenital inherited deafness in the midwestern United States. Screening of the GJB2 mutation can be offered to individuals with congenital deafness with high sensitivity and specificity by screening only for the 35delG mutation. A positive finding should establish an etiologic diagnosis and affect genetic counseling.


Author Affiliations: Molecular Otolaryngology Research Laboratories, Department of Otolaryngology, Head and Neck Surgery (Drs Green and Smith and Mr McDonald), Department of Pediatrics (Mr Scott and Dr Sheffield), and the Howard Hughes Medical Institute (Mr Scott and Dr Sheffield), University of Iowa Hospitals and Clinics, and the Department of Statistics and Actuarial Sciences (Dr Woodworth), University of Iowa, Iowa City. Drs Green, Sheffield, and Smith and Mr Scott contributed equally to this work.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

June 16, 1999
JAMA. 1999;281(23):2257-2258.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A novel hearing loss-related mutation occurring in the GJB2 basal promoter
Matos et al.
J. Med. Genet. 2007;44:721-725.
ABSTRACT | FULL TEXT  

Prelingual Siblings of Children With GJB2 Hearing Loss: Issues to Consider
Palmer et al.
Arch Otolaryngol Head Neck Surg 2005;131:1020-1022.
FULL TEXT  

Hereditary Non-Syndromic Sensorineural Hearing Loss: Transforming Silence to Sound
Schrijver
J. Mol. Diagn. 2004;6:275-284.
ABSTRACT | FULL TEXT  

A genotype-phenotype correlation for GJB2 (connexin 26) deafness
Cryns et al.
J. Med. Genet. 2004;41:147-154.
ABSTRACT | FULL TEXT  

Phenotypic Characterization of Hereditary Hearing Impairment Linked to DFNA25
Thirlwall et al.
Arch Otolaryngol Head Neck Surg 2003;129:830-835.
ABSTRACT | FULL TEXT  

Genotypic and Phenotypic Correlations of DFNB1-Related Hearing Impairment in the Midwestern United States
Lim et al.
Arch Otolaryngol Head Neck Surg 2003;129:836-840.
ABSTRACT | FULL TEXT  

Making Sense of Nonsyndromic Deafness
Smith and Huygen
Arch Otolaryngol Head Neck Surg 2003;129:405-406.
FULL TEXT  

Hereditary deafness and phenotyping in humans
Bitner-Glindzicz
Br Med Bull 2002;63:73-94.
ABSTRACT | FULL TEXT  

The Evaluation of Children With Sensorineural Hearing Loss
Greinwald and Hartnick
Arch Otolaryngol Head Neck Surg 2002;128:84-87.
FULL TEXT  

Universal Newborn Hearing Screening: Summary of Evidence
Thompson et al.
JAMA 2001;286:2000-2010.
ABSTRACT | FULL TEXT  

Autosomal recessive non-syndromic hearing loss in the Lebanese population: prevalence of the 30delG mutation and report of two novel mutations in the connexin 26 (GJB2) gene
Mustapha et al.
J. Med. Genet. 2001;38 :e36-e36.
FULL TEXT  

Connexin 26 Gene Mutations in Congenitally Deaf Children: Pitfalls for Genetic Counseling
Marlin et al.
Arch Otolaryngol Head Neck Surg 2001;127:927-933.
ABSTRACT | FULL TEXT  

Mutation Screening for Deafness: More Than Simply Another Diagnostic Test
Smith
Arch Otolaryngol Head Neck Surg 2001;127:941-942.
FULL TEXT  

A common founder for the 35delG GJB2 gene mutation in connexin 26 hearing impairment
Van Laer et al.
J. Med. Genet. 2001;38:515-518.
ABSTRACT | FULL TEXT  

trans-dominant inhibition of connexin-43 by mutant connexin-26: implications for dominant connexin disorders affecting epidermal differentiation
Rouan et al.
J. Cell Sci. 2001;114:2105-2113.
ABSTRACT | FULL TEXT  

Determination of the frequency of connexin26 mutations in inherited sensorineural deafness and carrier rates in the Tunisian population using DGGE
MASMOUDI et al.
J. Med. Genet. 2000;37:39e-39.
FULL TEXT  

Year 2000 Position Statement: Principles and Guidelines for Early Hearing Detection and Intervention Programs
Joint Committee on Infant Hearing et al.
Pediatrics 2000;106:798-817.
FULL TEXT  

Genetic Testing to Identify Deaf Newborns
Green et al.
JAMA 2000;284:1245-1245.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.